Tracking and Research
Accurately tracking congenital heart defects (CHDs) is the first step in preventing them and reducing their effect. Information from tracking systems provides a basis for research. Below is a summary of CDC’s CHD tracking and research work.
Importance of Tracking and Research
- Tracking: Birth defects tracking systems identify babies born with birth defects, including CHDs, and collect information to learn more about these conditions. Many states have birth defects tracking systems, which are vital to help us find out where and when birth defects occur, and who they affect.
- Research: We base our research on what we learn from tracking. By analyzing the collected data, we can identify factors that increase or decrease the risk of birth defects and identify community or environmental concerns or other factors, such as use of specific medications, which need more study.
CDC works to identify causes of heart defects, find opportunities to prevent them, and improve the health of those living with these conditions. Understanding the potential causes of heart defects can lead to recommendations, policies, and services to help prevent them. Researching health issues and needs across the lifespan can help us plan for services and ensure individuals born with these conditions are getting the care they need.
CDC’s tracking and research includes the following activities:
The Metropolitan Atlanta Congenital Defects Program
The Metropolitan Atlanta Congenital Defects Program (MACDP) is a population-based tracking system for birth defects, including CHDs, among children born to residents of metropolitan Atlanta. Established in 1967, MACDP is the nation's first population-based system to actively track birth defects. A population-based tracking program allows researchers to look at all of the people with a certain condition (like a CHD) who live in a specific area. This is done so that researchers can get a complete picture of what is happening within the population.
State Birth Defects Tracking Systems
Forty-one states have some level of birth defects tracking programs. CDC funds 14 states to track major birth defects, including CHDs, using population-based methods. State systems use the data to help direct birth defects prevention activities and refer children affected by birth defects to needed services.
National Birth Defects Prevention Network
CDC supports and works with the National Birth Defects Prevention Network (NBDPN). The NBDPN is a group of over 225 individuals working at the national, state, and local levels, who are involved in tracking, researching, and preventing birth defects. The network assesses the effects of birth defects on children, families, and the healthcare system. It also identifies factors that might increase or decrease the risk for having a baby with birth defects. This information is used to develop strategies to prevent birth defects and to assist families and their providers in preventing other disabilities among children with birth defects.
There are a number of state-based programs tracking CHDs among newborns and young children, but no population-based tracking system exists to look at the growing population of older children and adults with heart defects.
In 2012, CDC received funding to enhance and expand public health tracking of CHDs across the lifespan. From 2012 - 2015, CDC worked on a pilot project with the New York State Department of Health, Emory University in Atlanta, Georgia, and the Massachusetts Department of Public Health to develop population-based tracking of adolescents and adults with CHDs.
In 2015, a new project was started to expand upon the three-site pilot population-based tracking of adolescents and adults with CHDs. Five sites are involved in the expansion: Emory University, Duke University, University of Colorado - Denver, New York State Department of Health, and the University of Utah. These sites will work to better understand the survival, healthcare use, and longer term outcomes of individuals born with CHDs across the lifespan. Understanding health issues and needs at all ages is vital to improving the lives of individuals with these conditions.
Congenital Heart Surveillance To Recognize Outcomes, Needs, and well-beinG (CHSTRONG)
CDC is working on another project, CHSTRONG, a survey that will collect information on longer term outcomes, barriers to care, and quality of life for adult survivors of CHD. The information collected from this population-based survey will be used to inform the healthcare, educational, and social service needs of adults with CHDs. CDC, along with two other sites, plans to distribute the survey in 2016.
Centers for Birth Defects Research and Prevention Studies
CDC funds the Centers for Birth Defects Research and Prevention, which collaborate on two large studies of birth defects: the National Birth Defects Prevention Study (1997-2011) and the Birth Defects Study to Evaluate Pregnancy Exposures (began in 2014). These studies work to identify factors that increase or decrease the risk for having a baby with birth defects and to answer questions about exposures during pregnancy. Population-based studies like these look at the occurrence of conditions across a wide group of people, which is important to make sure that study results are applicable to all people in the United States.
Recently, CDC researchers and collaborators have reported important findings about some pregnancy exposures that increase the risk for CHDs:
- Obesity―Women who are obese before pregnancy have been shown to have an increased risk of having a pregnancy affected by a CHD. [Read article]
- Diabetes―Women with diabetes diagnosed before pregnancy have been shown to be more at risk of having a child with a number of birth defects, including CHDs. [Read summary]
- Smoking―Women who smoked anytime during the month before pregnancy through the end of the first trimester have been shown to be more likely to have a pregnancy affected by a CHD. [Read summary]
Reducing obesity, providing better control of diabetes, and preventing tobacco exposure are all actions we can take today that hold promise for preventing CHDs. These actions also might improve the health of those affected with CHDs throughout their lives.
Future Opportunities to Understand and Prevent CHDs
Following are some of the future activities for tracking and research of CHDs:
- Expand public health tracking of CHDs beyond the first year of life, to include children and adults
- Continue to investigate causes of CHDs
- Collect information on health outcomes across the lifespan
- Learn more about health service use among those with a CHD, including cost and quality of care
- Identify barriers in accessing care or in transitioning to adult care
- Increase awareness of the public health impact of CHDs
These activities are aimed at preventing CHDs, when possible, and improving the lives of those living with CHDs. [Read summary]
Key Findings: Newborn Screening for Critical Congenital Heart Defects Now Common Throughout the United States
In a new report in the journal, Pediatrics, CDC researchers and partners reviewed the overall effects of critical CHD screening, including costs and health outcomes (cost-effectiveness) of performing screenings, challenges at the state level for screening, and implementing screening in special settings.
(Published: April 15, 2016)
Key Findings — Use of Special Education Services among Children with CHDs
New CDC study findings in Pediatrics show that children with congenital heart defects (CHDs) received special education services more often than children without birth defects.
(Published: August 17, 2015)
Key Findings: State actions to adopt newborn screening for critical congenital heart defects
CDC’s Morbidity and Mortality Weekly Report has published a new study looking at state actions to adopt newborn screening for critical congenital heart defects (critical CHDs) using pulse oximetry – a simple, non-invasive way to measure the amount of oxygen in a newborn’s blood.
(Published: June 18, 2015)
Key Findings: Estimated Number of Infants Detected and Missed by Critical Congenital Heart Defect Screening
The journal Pediatrics has published a new study estimating the number of infants with critical congenital heart defects(critical CHDs) potentially detected or missed through universal screening for critical CHDs using pulse oximetry.
(Published: May 11, 2015)
Rapid Implementation of Statewide Mandate for Pulse Oximetry Newborn Screening to Detect Critical Congenital Heart Defects—New Jersey, 2011
New Jersey was the first state to pass a law and start a program where all licensed birthing hospitals are required to screen newborns for critical congenital heart defects. In the first three months of screening, about 98% of babies delivered were screened for critical congenital heart defects (CCHD).
(Published: July 9, 2014)
Key Findings: Prevalence of Congenital Heart Defects, Metro-Atlanta
From 1978-2005, the prevalence of more common (and less severe) congenital heart defects (CHDs) increased, while the prevalence of many severe CHDs remained stable. There are some differences in prevalence estimates between different racial/ethnic groups.
(Published: July 9, 2014)
Infant Death Due to Heart Defects
Congenital heart defects are conditions present at birth that can affect the way the heart works. They can cause lifelong disability or death. They are the most common type of birth defect, affecting nearly 40,000 births in the United States each year.
(Published: July 9, 2014)
Heart Defects Care for Life
Specialized care across the lifespan can help children and adults with a CHD live as healthily as possible.
(Published: February 9, 2015)
Heart Defects Study
Heart defects across the lifespan.
(Published: February 10, 2014)
Five Facts about Congenital Heart Defects
Congenital heart defects are the most common types of birth defects. They affect nearly 40,000 infants born in the US each year.
(Published: January 10, 2012)
- Page last reviewed: December 23, 2015
- Page last updated: December 23, 2015
- Content source: